Skip to main content
MHRP

Main navigation

  • About Us
    • Our Team
      • Leadership
      • Researchers
      • Global Health
      • Labs
    • WRAIR
    • HJF
    • Impact
    • Fact Sheets
    • Newsletters
    • Contact Us
  • PEPFAR
    • Kenya
    • Nigeria
    • Tanzania
    • Uganda
    • Philippines
  • HIV Research
    • Vaccine Research
      • Vaccine Approaches
      • MFV Vaccine Design
      • ALF Adjuvants
      • RV144 Thai Trial
    • Monoclonal Antibodies (mAbs)
      • Bispecific Antobodies
    • Acute HIV and Cure Research
      • RV217
      • RV254
      • HIV Cure
      • Martin Delaney Collaboratories
    • Epidemiology and Threat Assessment
      • Cohorts and Other Observational Studies
      • Clinical Trials
  • Global Research
    • Georgia
    • Germany
    • Jordan
    • Kenya
    • Mozambique
    • Nigeria
    • Tanzania
    • Thailand
    • Uganda
    • Philippines
  • News
  • Careers
    • Benefits & Culture
    • Current Opportunities
    • International Careers
    • Meet the Team
  • Search
HIV prevention soccer shirts

News


Media Contact

Lisa Reilly
Chief of Communications
Phone
301-500-3600
Email
lreilly@hivresearch.org

News

Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine

Nov 7, 2016

News

MHRP Scientists and Collaborators Detect Declining Trend in Transmitted Drug Resistance in Acute HIV Infection Cohort

Nov 3, 2016

Prevalence among cohort has fallen below WHO low-level guideline

News

New MHRP PEPFAR-funded Study to Examine Malaria and TB HIV Co-infection in Kenyan Defence Forces

Oct 31, 2016

News

MHRP and Collaborators at HIV Research for Prevention (HIVR4P) 2016

Oct 13, 2016

Press Release

New Investigational HIV Therapeutic Vaccine Approach Helps Control SIV in Preclinical Studies

Oct 9, 2016

New Investigational HIV Therapeutic Vaccine Approach  Helps Control SIV in Preclinical Studies

Press Release

Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine

Oct 7, 2016

Human Trials Begin for Army-Developed Zika Purified Inactivated Virus (ZPIV) Vaccine

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 23
  • Page 24
  • Current page 25
  • Page 26
  • Page 27
  • …
  • Next page Next ›
  • Last page Last »

Sign Up For Our Newsletter

WRAIR WRAIR MHRP
HJF HJF

Social Navigation

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Footer

  • Accessibility
  • Disclaimers
  • Privacy
  • Contact MHRP

©2022 Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

This site was created by HJF. The appearance of U.S. Department of Defense visual information does not imply or constitute DoD endorsement.